Clare Gomez
Primary Care · Cartersville, GANPI 1871292607
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.1% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Lilly USA, LLC at 36.6% of the total. 2025 is the largest year on record at $837, 9.3 times the $90 reported in 2023.
Across 92 payments — averaging $16.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$571
- Novo Nordisk$220
- Pfizer$181
- Amgen$106
- AstraZeneca$101
- Exact Sciences$100
- plus $282 from 11 others
What the payments were for
- Food & beverage$1,51897%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 37 | $571 |
| Novo Nordisk | 11 | $220 |
| Pfizer | 10 | $181 |
| Amgen | 7 | $106 |
| AstraZeneca | 6 | $101 |
| Exact Sciences | 6 | $100 |
| AbbVie | 3 | $45 |
| Novartis | 2 | $41 |
| Boehringer Ingelheim | 2 | $37 |
| Pulmonx Corporation | 1 | $32 |
| Astellas Pharma US Inc | 1 | $22 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $19 |
| Saluda Medical Americas, Inc. | 1 | $19 |
| Medtronic | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$1,563 in reported general payments places this provider in the 75th percentile of 235 primary care providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fenofibrate | 14 | $549 |
| Atorvastatin Calcium | 52 | $415 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $384 |
| Diclofenac Sodium | 15 | $290 |
| Rosuvastatin Calcium | 24 | $268 |
| Levothyroxine Sodium | 33 | $249 |
| Losartan Potassium | 25 | $181 |
| Trazodone Hcl | 17 | $178 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 14 | $167 |
| Lisinopril | 39 | $157 |
| Buspirone Hcl | 13 | $145 |
| Metformin Hcl | 32 | $143 |
| Pantoprazole Sodium | 17 | $142 |
| Fluticasone Propionate | 13 | $115 |
| Pravastatin Sodium | 12 | $111 |
Paid to pharmacies, not to this prescriber.
Other primary care in Cartersville
- Ginger YrabedraCartersville$4K
- Pamela TurkDouglas$15K
- Morgan JonesLawrenceville$14K
- Jessi HaleColumbus$13K
- Meredith CarrAugusta$12K
- Ashtyn ZaryckiSavannah$12K
- Zanetta BryantNewnan$11K
- Hannah CummingsSuwanee$9K
- Michelle LadewigGainesville$7K
- Lucia OcanoviciuCanton$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.